comparemela.com
Home
Live Updates
Ophthalmology Biosimilars Show Similar Safety, Efficacy to R
Ophthalmology Biosimilars Show Similar Safety, Efficacy to R
Ophthalmology Biosimilars Show Similar Safety, Efficacy to Reference Eylea and Lucentis
The results for a proposed aflibercept (Eylea) biosimilar and an accepted ranibizumab (Lucentis) biosimilar were presented at Euretina Congress 2023.
Related Keywords
Netherlands ,
United States ,
Amsterdam ,
Noord Holland ,
Samsung Bioepis ,
Artem Markin ,
Hyejin Kim ,
Euretina Congress ,
European Union ,
Biosimilars ,
Aflibercept ,
Eylea ,
Ranibizumab ,
Byooviz ,
Lucentis ,
Ophthalmology ,